12:12, 19 April 2016 (diff | hist) . .(+2,792) . . N Therapy response monitoring in rheumatoid arthritis (Created page with "=Monitoring the therapeutic effect of long-circulation liposomal glucocorticoids in a murine arthritis model using 18F-FDG PET/CT= Corticosteroids, such as Prednisolon Phosph...")
12:07, 19 April 2016 (diff | hist) . .(+1,799) . . N Image-guided surgery with fluorescent labeled antibodies (Created page with "=Image-guided surgery: radionuclide and fluorescence imaging with dual-labeled antibodies= Accurate tumor identification is essential in the management of cancer patients. Fo...")(current)
12:05, 19 April 2016 (diff | hist) . .(+2,742) . . N Pretargeting of cancer (Created page with "__NOTOC__={{PAGENAME}}= The use of radiolabeled monoclonal antibodies (MAbs) directed against tumor-associated antigens for cancer imaging and therapy has been widely studi...")(current)
11:51, 19 April 2016 (diff | hist) . .(+2,018) . . N Radioimmunotherapy of cancer (Created page with "__NOTOC__={{PAGENAME}}= Monoclonal antibodies or pretargeting strategies can be used to specifically deliver radionuclides to the tumor, while sparing normal tissue. Two ex...")(current)
11:40, 19 April 2016 (diff | hist) . .(+1,957) . . N Antibodies imaging for immune check point inhibitors (Created page with "__NOTOC__={{PAGENAME}}= Our immune system is capable of recognizing and eliminating cancer cells. This process is tightly regulated by immune checkpoints and their ligands....")
11:31, 19 April 2016 (diff | hist) . .(+946) . . N Antibody peptide and small molecule labeling (Created page with "__NOTOC__={{PAGENAME}}= Development of novel radiolabeled tracers for in vivo targeting. Proteins (antibodies), peptides, small molecules and liposomes are labelled with va...")(current)
11:04, 19 April 2016 (diff | hist) . .(+1,952) . . N Imaging of beta cells (Created page with "__NOTOC__={{PAGENAME}}= After Roux-en-Y gastric bypass surgery (RYGB, see Figure), changes in the glucose homeostasis are observed. In patients with type 2 diabetes mellitu...")
